Management of head and neck cancer
作者： U. Tirelli , G. Franchin , L. Barzan
DOI: 10.1093/OXFORDJOURNALS.ANNONC.A058912
关键词:
摘要: Malignancies arising in the head and neck area are heterogeneous diseases, each with its own natural history prognosis. Cancer of larynx, for example, has a better prognosis than cancer hypopharynx [1]. However, due to relatively low number cases anatomic site, because predominant lesion is squamous cell carcinoma, they usually considered together clinical trials.
springer.com
elsevier.com
sci-hub.se 参考文章(55)
Gerold Fp, Shah J, Strong Ew, Cvitkovic E, Wittes Re, CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. Cancer treatment reports. ,vol. 61, pp. 359- ,(1977)
Schuller De, Kish J, Ensley J, Metch B, Rinehart Jj, Coltman Ca, Al-Sarraf M, Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study. Cancer treatment reports. ,vol. 71, pp. 723- 726 ,(1987)
V A Marcial, T F Pajak, M Al-Sarraf, J Stetz, S Kramer, G E Laramore, L W Brady, L W Davis, J R Jacobs, Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer. Seminars in Oncology. ,vol. 15, pp. 39- 60 ,(1988)
Bruce A. Chabner, Chien-Song Kao-Shan, Elaine C. Lee, Robert L. Fine, Jacqueline Whang-Peng, Increased Fragile Sites and Sister Chromatid Exchanges in Bone Marrow and Peripheral Blood of Young Cigarette Smokers Cancer Research. ,vol. 47, pp. 6278- 6282 ,(1987)
Monica B. Spaulding, Anjum Kahn, Rafael De Los Santos, Douglas Klotch, John M. Loré, Adjuvant chemotherapy in advanced head and neck cancer. An update. American Journal of Surgery. ,vol. 144, pp. 432- 436 ,(1982) , 10.1016/0002-9610(82)90417-2
K K Fu, T L Phillips, I J Silverberg, C Jacobs, D R Goffinet, C Chun, M A Friedman, M Kohler, K McWhirter, S K Carter, Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. Journal of Clinical Oncology. ,vol. 5, pp. 1410- 1418 ,(1987) , 10.1200/JCO.1987.5.9.1410
M Eisenberger, J Hornedo, H Silva, R Donehower, M Spaulding, D Van Echo, Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck. Journal of Clinical Oncology. ,vol. 4, pp. 1506- 1509 ,(1986) , 10.1200/JCO.1986.4.10.1506
Stephen P. Cragle, James H. Brandenburg, Laser Cordectomy or Radiotherapy: Cure Rates, Communication, and Cost: Otolaryngology-Head and Neck Surgery. ,vol. 108, pp. 648- 654 ,(1993) , 10.1177/019459989310800605
T J Ervin, J R Clark, R R Weichselbaum, B G Fallon, D Miller, R L Fabian, M R Posner, C M Norris, S A Tuttle, D A Schoenfeld, An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. Journal of Clinical Oncology. ,vol. 5, pp. 10- 20 ,(1987) , 10.1200/JCO.1987.5.1.10
Waun KI Hong, Scott M. Lippman, Loretta M. Itri, Daniel D. Karp, Jin S. Lee, Robert M. Byers, Stimson P. Schantz, Alan M. Kramer, Reuben Lotan, Lester J. Peters, Isaiah W. Dimery, Barry W. Brown, Helmuth Goepfert, Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. The New England Journal of Medicine. ,vol. 323, pp. 795- 801 ,(1990) , 10.1056/NEJM199009203231205